| Literature DB >> 881101 |
E Vïsänen, P Ranta, A Nummikko-Pelkonen, P Tienari.
Abstract
Nine patients with severe primary obsessional illness were treated with mianserin hydrochloride (Org GB 94), in a dose increasing to 20 mg three times daily, for 4 weeks. Six patients improved as assessed by a physician's global rating of improvement. The symptoms on a side-effects check list were less marked during treatment than they had been during the pre-treatment drug-free period.Entities:
Mesh：
Substances：
Year: 1977 PMID： 881101 DOI： 10.1177/030006057700500411
Source DB: PubMed Journal: J Int Med Res ISSN： 0300-0605 Impact factor: 1.671